9th Sep 2005 07:00
Sinclair Pharma PLC09 September 2005 9 September 2005 Sinclair Pharma plc Appointment of new advisers The Company today announces the appointment of Piper Jaffray Ltd. as nominatedadviser and joint broker with immediate effect. In addition, the Companyannounces the appointment of Nomura International plc as joint broker, withimmediate effect. Piper Jaffray Ltd. and Nomura International plc will actalongside Robert W. Baird who will remain in their existing role. Enquiries: Sinclair Pharma plcDr Michael Flynn, CEO Tel: 01483 426 644John Barrington-Carver (Media Enquiries) Tel: 07831 655 630 Financial DynamicsBen Atwell / Lucy Briggs Tel: 0207 831 3113 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma